| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.64▲ | 1.63▲ | 1.62▲ | 1.56▲ | 1.45▲ |
| MA10 | 1.63▲ | 1.61▲ | 1.60▲ | 1.53▲ | 1.69▼ |
| MA20 | 1.63▲ | 1.59▲ | 1.55▲ | 1.44▲ | 5.80▼ |
| MA50 | 1.60▲ | 1.52▲ | 1.53▲ | 1.68▼ | 9.99▼ |
| MA100 | 1.58▲ | 1.52▲ | 1.48▲ | 6.32▼ | 13.17▼ |
| MA200 | 1.53▲ | 1.46▲ | 1.43▲ | 9.72▼ | 15.54▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | 0.004▲ | 0.009▲ | 0.093▲ | -0.192▼ |
| RSI | 61.722▲ | 68.119▲ | 69.635▲ | 49.011▼ | 22.882▼ |
| STOCH | 88.148▲ | 75.851 | 86.684▲ | 69.946 | 11.238▼ |
| WILL %R | -11.111▲ | -5.556▲ | -2.632▲ | -1.471▲ | -95.374▼ |
| CCI | 128.881▲ | 153.419▲ | 141.085▲ | 168.328▲ | -50.324 |
|
Thursday, May 01, 2025 01:05 PM
Implementation of cost reduction initiatives to position Pliant for execution of late-stage clinical trials - Pliant will reduce its current workforce by approximately 45% - Closing activities for ...
|
|
Tuesday, April 22, 2025 05:00 PM
SOUTH SAN FRANCISCO, Calif., April 07, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that the Company will present three scientific posters at the upcoming 2025 ...
|
|
Wednesday, April 16, 2025 11:45 AM
NEW YORK CITY, NY / ACCESS Newswire / April 16, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Pliant Therapeutics, Inc ("Pliant" or the "Company") (NASDAQ:PLRX).
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 02/05/25 | 1.63 | 1.65 | 1.605 | 1.645 | 94,969 |
| 01/05/25 | 1.58 | 1.6399 | 1.51 | 1.62 | 703,768 |
| 30/04/25 | 1.46 | 1.60 | 1.43 | 1.59 | 843,447 |
| 29/04/25 | 1.47 | 1.53 | 1.455 | 1.47 | 526,591 |
| 28/04/25 | 1.46 | 1.48 | 1.43 | 1.47 | 472,941 |
| 25/04/25 | 1.54 | 1.55 | 1.45 | 1.46 | 653,189 |
| 24/04/25 | 1.54 | 1.58 | 1.52 | 1.57 | 408,911 |
| 23/04/25 | 1.535 | 1.58 | 1.53 | 1.54 | 806,549 |
| 22/04/25 | 1.50 | 1.525 | 1.45 | 1.50 | 647,544 |
| 21/04/25 | 1.42 | 1.59 | 1.41 | 1.48 | 1,014,647 |
|
|
||||
|
|
||||
|
|